ariadne.ai ag is a Swiss-based startup specializing in AI-powered biomedical image analysis. Since its establishment in 2014, the company has positioned itself as a contract research organization (CRO) catering to automated high-throughput biomedical image analysis and cutting-edge image processing technology. By providing scalable and consistent solutions, ariadne.ai ag aims to accelerate research and development efforts by addressing image processing and analysis bottlenecks. The interdisciplinary team of scientists and machine-learning experts leverages human and artificial intelligence to convert extensive imaging data into quantitative results and develop novel, imaging-based, AI-powered biomarkers. Their portfolio encompasses workflows for high-throughput screening, colocalization, image alignment and registration, as well as light, fluorescence, and electron microscopy. Despite the absence of publicly disclosed information regarding their last investment, ariadne.ai ag stands at the forefront in the Biotechnology, Computer Vision, and Information Technology industries, pioneering innovative solutions in the field of image analysis and processing.
There is no investment information
No recent news or press coverage available for ariadne.ai ag.